[Occupational medical aspects of COVID-19 pandemic containment: experiences from a large chemical company]. / Arbeitsmedizinische Aspekte bei der Eindämmung der COVID-19-Pandemie: Erfahrungen aus einem Großunternehmen der chemischen Industrie.
Dtsch Med Wochenschr
; 148(13): e65-e75, 2023 Jul.
Artículo
en Alemán
| MEDLINE | ID: covidwho-20234277
ABSTRACT
INTRODUCTION:
With the present paper we aim to describe the experience of a large chemical company in tackling the COVID-19 pandemic. Specifically, we describe the timing and content of implemented measures and outline the course of the pandemic from the company's perspective.METHODS:
We describe the infection protection measures and the pandemic course at the company's main site in Ludwigshafen (Germany) from March 2020 to May 2022. Company-specific data on the date of reporting an infection, suspected place of infection, number of close contacts, and the employee group were used to calculate 7-day-incidences and visualized, among other things, by means of a plant map (active infections) and a network chart (chains of infection). In addition, a weighted average of the incidences from districts close to the plant (weighted by the number of resident employees within the district) was calculated using publicly available data by the Robert Koch Institute and compared with the course of company-specific incidences.RESULTS:
At the end of follow-up on 31st May 2022, 9,379 infections with SARS-CoV-2 had been recorded in employees and 758 more in leasing staff, including 368 (4%) and 84 (11%) suspected infections at the workplace/on-site, respectively. The course of 7-day incidences among employees was mainly consistent with that in the surrounding districts. The incidence of suspected infections on-site/at the workplace remained predominantly at a comparatively low level below 100 new infections over 7 days/100,000.DISCUSSION:
The continuous monitoring and analysis of new SARS-CoV-2 cases among employees provides valuable information for the effective management of protective measures in the company. It enables a targeted response to changes in the number of new cases on the plant site by tightening or relaxing protective measures.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
Tipo de estudio:
Estudio de cohorte
/
Estudio observacional
/
Estudio pronóstico
/
Investigación cualitativa
Límite:
Humanos
País/Región como asunto:
Europa
Idioma:
Alemán
Revista:
Dtsch Med Wochenschr
Año:
2023
Tipo del documento:
Artículo
País de afiliación:
A-2075-5488
Similares
MEDLINE
...
LILACS
LIS